相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells
J. Leja et al.
GENE THERAPY (2011)
Oncolytic Viruses for the Treatment of Neuroendocrine Tumors
M. Essand et al.
HORMONE AND METABOLIC RESEARCH (2011)
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang et al.
NATURE MEDICINE (2011)
Secondary structure of cell-penetrating peptides controls membrane interaction and insertion
Emelia Eiriksdottir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)
Varying Opinions on the Authenticity of a Human Midgut Carcinoid Cell Line - Letter
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2010)
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors
S. Pesonen et al.
GENE THERAPY (2010)
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood
A. Danielsson et al.
GENE THERAPY (2010)
Intracellular transduction using cell-penetrating peptides
Rupa Sawant et al.
MOLECULAR BIOSYSTEMS (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy
Stephen H. Thorne et al.
MOLECULAR THERAPY (2010)
Enhancing the Therapeutic Effect Against Ovarian Cancer Through a Combination of Viral Oncolysis and Antigen-specific Immunotherapy
Yu-Qian Zhang et al.
MOLECULAR THERAPY (2010)
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
Justyna Leja et al.
PLOS ONE (2010)
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba et al.
BLOOD (2009)
Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors
Sergey S. Seregin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Expanded Anticancer Therapeutic Window of Hexon-modified Oncolytic Adenovirus
Elena V. Shashkova et al.
MOLECULAR THERAPY (2009)
Fiber Mediated Receptor Masking in Non-Infected Bystander Cells Restricts Adenovirus Cell Killing Effect but Promotes Adenovirus Host Co-Existence
Johan Rebetz et al.
PLOS ONE (2009)
Transduction of adenovirus vectors modified with cell-penetrating peptides
Yusuke Eto et al.
PEPTIDES (2009)
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function
Richard J. Stanton et al.
BIOTECHNIQUES (2008)
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region
A. Danielsson et al.
CANCER GENE THERAPY (2008)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Targeting of Adenovirus Vectors to the LRP Receptor Family With the High-affinity Ligand RAP via Combined Genetic and Chemical Modification of the pIX Capsomere
Stephanie Corjon et al.
MOLECULAR THERAPY (2008)
Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver
Frederic Vigant et al.
MOLECULAR THERAPY (2008)
Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency
Yasuo Yoshioka et al.
LIFE SCIENCES (2008)
Protein Crystals in Adenovirus Type 5-Infected Cells: Requirements for Intranuclear Crystallogenesis, Structural and Functional Analysis
Laure Franqueville et al.
PLOS ONE (2008)
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob
Hongjie Wang et al.
JOURNAL OF VIROLOGY (2007)
The development and characterization of a human midgut carcinoid cell line
George Van Buren et al.
CLINICAL CANCER RESEARCH (2007)
Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity
S. Kurachi et al.
GENE THERAPY (2007)
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
Justyna Leja et al.
CLINICAL CANCER RESEARCH (2007)
Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid
J. Vellinga et al.
GENE THERAPY (2007)
Automated, high-resolution cellular retention and uptake studies in vitro
Henrik Bjorke et al.
APPLIED RADIATION AND ISOTOPES (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors
F Kreppel et al.
MOLECULAR THERAPY (2005)
Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus type 5 for the treatment of high-risk neuroblastomas in preclinical models
NS Parikh et al.
PEDIATRIC BLOOD & CANCER (2005)
Expression of P53, or targeting towards EGFR, enhances the oncotytic potency of conditionalty repticative adenovirus against neuroblastoma
B Geoerger et al.
JOURNAL OF GENE MEDICINE (2005)
Identification of sites in adenovirus hexon for foreign peptide incorporation
HJ Wu et al.
JOURNAL OF VIROLOGY (2005)
Cell-penetrating peptides: Mechanisms and applications
S El-Andaloussi et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer
GJ Bauerschmitz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer
WS Cheng et al.
MOLECULAR THERAPY (2004)
Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods
JJ Rux et al.
JOURNAL OF VIROLOGY (2003)
Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators
B Carlsson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity
JA Leifert et al.
GENE THERAPY (2002)
ESyPred3D:: Prediction of proteins 3D structures
C Lambert et al.
BIOINFORMATICS (2002)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
分享论文
